Characterization of four types of tail abnormalities in rats treated prenatally with valproic acid
Resumen
El ácido valpróico (AVP) es un fármaco anticonvulsivo usado principalmente para el tratamiento de la epilepsia, trastorno bipolar y esquizofrenia. Se ha demostrado que el AVP es un teratógeno potente que causa defectos de nacimiento y malformaciones. Así mismo, hay informes que sugieren una relación entre el uso de AVP durante el embarazo y un aumento de la incidencia de niños con trastornos neurológicos tales como el espectro autista. En los seres humanos, la exposición prenatal a la AVP produce malformaciones que sugieren un defecto durante el cierre del tubo neural, como es el caso de la espina bífida, enfermedades del corazón, defectos de las extremidades, anomalías craneofaciales, así como anomalías genitales. En el presente trabajo se describen cuatro anormalidades de la cola en ratas tratadas prenatalmente con ácido valpróico. Este tratamiento se ha utilizado como modelo animal para el estudio de rasgos autistas. Estas malformaciones pudieran estar asociadas con algún daño en el sistema nervioso, sin embargo se requieren más estudios para correlacionar cada anormalidad de la cola con el tipo de alteración neural.
Abstract
Valproic acid (VPA) is an anticonvulsant drug used mainly for the treatment of epilepsy, bipolar disorder and schizophrenia. The VPA has been shown to be a potent teratogen that causes birth defects and malformations. Likewise, there are reports that suggest a relationship between the use of VPA during pregnancy and an increased incidence of children with neurological disorders such as autism. In humans, prenatal exposure to VPA produces malformations including dimorphic facial features suggestive of a lesion in the neural tube, as in the case of spina bifida, heart disease, limb defects and craniofacial anomalies as well as genital abnormalities. Herein we describe four tail abnormalities found in rats treated prenatally with valproic acid, which has been used as an animal model for the study of autistic features. These malformations may be associated with neural damage, but further studies are needed in order to correlate each tail abnormality with the kind of neural alteration.
Keywords: Teratogen; valproic acid; animal model; malformations; neural tube defects.
Palabras clave
Texto completo:
PDFReferencias
Gugler R and von Unruh GE. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1980 5: 67-83.
Wu P, Jiang L, Chen H. Sodium valproate at the therapeutic concentration inhibits the induction but not the maintenance phase of long-term potentiation in rat hippocampal CA1 area. Biochem Bioph Res Co 2010 391: 582-586.
Kostrouchova M, Kostrouch Z, Kostrouchová M. Valproic acid, a molecular lead to multiple regulatory pathways. Folia Biol-Praha 2007 53: 37.
Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. Int Clin Psychopharm 2003 18: 169- 172.
Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT. Valproic acid monotherapy in pregnancy and major congenital malformations. New Engl J Med 2010 362: 2185-2193.
Pardal-Fernández JM, Carrascosa-Romero MC, Rodríguez-Vázquez M, Marco-Giner J, Martínez-Gutiérrez A. Embriopatía por ácido valproico con malformaciones graves del sistema nervioso central. Rev Neurología 2006 42: 336- 340.
Rodier PM, Ingram JL, Tisdale B, Croog VJ. Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 1997 11: 417-422.
Koren G, Nava-Ocampo AA, Moretti ME, Sussman R, Nulman I. Major malformations with valproic acid. Can Fam Physician 2006 52: 441-442.
Sonoda T, Ohdo S, Ohba KI, Okishima T, Hayakawa K. Sodium valproate‐induced cardiovascular abnormalities in the Jcl: ICR mouse fetus: Peak sensitivity of gestational day and dose‐dependent effect. Teratology 1993 48: 127-132.
Wu G, Nan C, Rollo JC, Huang X, Tian J. Research Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase. Biomed Sci 2010 17: 16-22.
Menegola E, Broccia ML, Nau H, Prati M, Ricolfi R, Giavini E. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term. Teratogen Carcin Mut 1996 16: 97-108.
Faiella A, Wernig M, Consalez GG, Hostick U, Hofmann C, Hustert E, Nadeau JH. A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 2000 9: 227-236.
Downing C, Biers J, Larson C, Kimball A, Wright H, Ishii T, Johnson T. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. Toxicol Sci 2010 116: 632-639.
Ingram JL, Peckham SM, Tisdale B, Rodier PM. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 2000 22: 319-24.
Rodier PM, Ingram JL, Tisdale B, Nelson S, Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996 370: 247-261.
Markram H, Rinaldi T, Markram K. The intense world syndrome–an alternative hypothesis for autism. Front Neurosci 2007 1: 77.
Markram K, Rinaldi T, La Mendola D, Sandi C, Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2007 33: 901-912.
Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2004 30: 80-89.
Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002 6: 248-254.
Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, Przewłocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrino 2008 33: 728-740.
Vanhoutte G, Verhoye M, Raman E, Roberts M, Linden A. In‐vivo non‐invasive study of the thermoregulatory function of the blood vessels in the rat tail using magnetic resonance angiography. NMR Biomed 2002 15: 263-269.
Hickman GC. The mammalian tail: a review of functions. Mammal Rev 1979 9: 143-157.
Tung EW, Winn LM. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Mol Pharmacol 2011 80: 979-987.
Sarachana T, Xu M, Wu RC, Hu VW. Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PLoS One 2011 6: e17116.
Barr M, Brent RL. The relation of the uterine vasculature to fetal growth and the intrauterine position effect in rats. Teratology 1970 3: 251-260.
Yan RH, Bunning M, Wahlsten D, Hurd, PL. Digit Ratio (2D∶ 4D) Differences between 20 Strains of Inbred Mice. 2009 PloS one 4(6), e5801.
Manning JT, Callow M, Bundred PE. Finger and toe ratios in humans and mice: implications for the aetiology of diseases influenced by HOX genes. Medical Hypotheses 2003 60(3), 340-343.
Ryan BC, Vandenbergh JG. Intrauterine position effects. Neurosci Biobehav Rev 2002 26(6), 665-678.
Mitchell ES, Keller Jr RW, Snyder-Keller A. Immediate-early gene expression in concurrent prenatal ethanol-and/or cocaine-exposed rat pups: intrauterine differences in cocaine levels and Fos expression. Dev Brain Res 2002 133: 141-149.
Enlaces refback
- No hay ningún enlace refback.
eNeurobiología es una publicación cuatrimestral editada por el Instituto de Investigaciones Cerebrales de la Universidad Veracruzana. Estamos ubicados en Av. Dr. Luis Castelazo Ayala, s/n, colonia Industrial Ánimas, C.P. 91190, Xalapa-Enríquez, Veracruz, México. Teléfono: 8418900 ext. 13062, www.iice.uv.mx; eneurobiologia@uv.mx. Reserva de Derechos al Uso Exclusivo 04-2023-061314100600-102, otorgada por el Instituto Nacional de Derechos de Autor. ISSN: 2007-3054. Esta obra está bajo una Licencia Creative Commons Attribution 4.0 International.